Pulmonary Hypertension Due to Lung Diseases
4 clinical trials · Condition
◉ Watch Pulmonary Hypertension Due to Lung Diseases
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD (NCT04691154) | Liquidia Technologies, Inc. | 2021-08-01 |
Track Pulmonary Hypertension Due to Lung Diseases automatically
Every clearance here is in the API, with alerts when new ones post.